Patents Assigned to Merck Patents GmbH
  • Publication number: 20180071386
    Abstract: The invention relates to ultrasmall, monodisperse nanoparticles comprising silicon dioxide to the surface of which at least one antigen is attached. The nanoparticles can be used for the immunoprophylaxis or immunotherapy of cancer. The invention also relates to a method for the targeting of antigens at antigen-presenting cells and for the activation of the immune system, where the efficiency of targeting and/or immunoactivation are set via the particle characteristics. The invention also relates to a method for the active and passive immunisation of a mammal.
    Type: Application
    Filed: October 6, 2017
    Publication date: March 15, 2018
    Applicant: Merck Patent GmbH
    Inventors: Markus Weigandt, Andrea Hanefeld, Armin Kuebelbeck, Gregor Larbig
  • Publication number: 20180072715
    Abstract: Compounds of the formula (I), which are ATM kinase inhibitors and can be employed, inter alia, for the treatment of cancer.
    Type: Application
    Filed: March 31, 2016
    Publication date: March 15, 2018
    Applicant: Merck Patent GmbH
    Inventors: Thomas FUCHSS, Kai SCHIEMANN
  • Patent number: 9914877
    Abstract: The present invention relates to a liquid crystal panel, a liquid crystal display device and to a liquid crystal medium having a negative dielectric anisotropy ??.
    Type: Grant
    Filed: October 31, 2011
    Date of Patent: March 13, 2018
    Assignee: MERCK PATENT GMBH
    Inventors: Eun-Kyu Lee, Seung-Eun Lee, Dong-Mee Song
  • Patent number: 9917272
    Abstract: The present application relates to an electronic device comprising a hole-transport layer A, a doped hole-transport layer B and a hole-transport layer C, where hole-transport layers A, B and C are arranged between the anode and the emitting layer, and where hole-transport layer B is arranged on the cathode side of hole-transport layer A and hole-transport layer C is arranged on the cathode side of hole-transport layer B.
    Type: Grant
    Filed: September 11, 2013
    Date of Patent: March 13, 2018
    Assignee: Merck Patent GmbH
    Inventors: Frank Voges, Jonas Valentin Kroeber, Christof Pflumm, Joachim Kaiser, Arne Buesing
  • Patent number: 9914742
    Abstract: The present invention relates compounds comprising a tetra-heteroaryl indacenodithiophene-based structural unit, the synthesis of such compounds as well as their use in organic electronic devices. The invention further relates to organic electronic devices comprising such compounds.
    Type: Grant
    Filed: June 26, 2015
    Date of Patent: March 13, 2018
    Assignee: Merck Patent GmbH
    Inventors: William Mitchell, Mansoor D'Lavari, Changsheng Wang, David Sparrowe
  • Patent number: 9914876
    Abstract: The invention relates to bimesogenic compounds of formula I wherein R11, R12, MG11, MG12, X11, X12 and Sp1 have the meaning given in claim 1, to the use of bimesogenic compounds of formula I in liquid crystal media and particular to flexoelectric liquid crystal devices comprising a liquid crystal medium according to the present invention.
    Type: Grant
    Filed: June 14, 2013
    Date of Patent: March 13, 2018
    Assignee: Merck Patent GmbH
    Inventors: Kevin Adlem, Owain Llyr Parri, Rachel Tuffin, Patricia Eileen Saxton, Benjamin Snow, Mark John Goulding, Nathan Smith
  • Patent number: 9914702
    Abstract: The present invention relates to compounds useful in the modulation of potassium channel activity in cells, in particular the activity of Kv1.3 channels found in T cells. The invention also relates to the use of these compounds in the treatment or prevention of autoimmune and inflammatory diseases, including multiple sclerosis, pharmaceutical compositions containing these compounds and methods for their preparation.
    Type: Grant
    Filed: December 1, 2016
    Date of Patent: March 13, 2018
    Assignees: Bionomics Limited, Merck Patent GmbH
    Inventors: Andrew Harvey, Agnes Bombrun, Rachel Cooke, Isabelle Jeanclaude-Etter, Nathan Kuchel, Jerome Molette, Jorgen Mould, Dharam Paul, Rajinder Singh, Cristina Donini, Veronique Colovray, Thomas Avery, Julia Crossman, Justin Ripper
  • Publication number: 20180066000
    Abstract: The present invention relates to metal complexes having a metal atom of groups 13 to 15 and at least one ligand, where the ligand comprises at least one anionic coordination group having at least one oxygen and/or nitrogen atom via which the metal atom is coordinated, and the ligand comprises at least one triarylamine group, to processes for preparation thereof and to the use thereof in electronic devices, especially in organic electroluminescent devices, called OLEDs (OLED=organic light emitting diode). The present invention also further relates to organic electroluminescent devices comprising these metal complexes.
    Type: Application
    Filed: April 19, 2016
    Publication date: March 8, 2018
    Applicant: MERCK PATENT GMBH
    Inventors: Philipp Stoessel, Dominik Joosten, Beate Burkhart, Katja Stegmaier
  • Publication number: 20180066186
    Abstract: The present invention relates to alkaline earth aluminate phosphors, to a process for the preparation thereof and to the use thereof as conversion phosphors. The present invention also relates to an emission-converting material comprising at least the conversion phosphor according to the invention, and to the use thereof in light sources, in particular pc-LEDs (phosphor converted light emitting devices). The present invention furthermore relates to light sources, in particular pc-LEDs, and to lighting units which comprise a primary light source and the emission-converting material according to the invention.
    Type: Application
    Filed: March 2, 2016
    Publication date: March 8, 2018
    Applicant: MERCK PATENT GMBH
    Inventors: Aleksander ZYCH, Mathias RAPPHAHN, Ralf PETRY, Ingo KOEHLER, Andreas BENKER, Stefan TEWS
  • Patent number: 9908863
    Abstract: The present invention provides compounds of Formula (I) for the treatment of parasitic diseases including malaria, as well as neurodegenerative diseases. Formula (I) wherein R3, R4, X and Y have the meaning given in claim 1.
    Type: Grant
    Filed: December 27, 2013
    Date of Patent: March 6, 2018
    Assignee: MERCK PATENT GMBH
    Inventors: Julie Routier, Thomas Spangenberg
  • Patent number: 9909010
    Abstract: The present invention relates to interference pigments based on multicoated flake-form substrates which have on the surface of the substrate a layer sequence comprising (A0) optionally a high-refractive-index coating consisting of a layer of TiO2, (A) a high-refractive-index coating consisting of a mixture of TiO2 and Fe2O3, which may optionally be doped with one or more further oxides, (B) a high-refractive-index layer consisting of SnO2, (C) a high-refractive-index coating which absorbs in the visible wavelength region, and optionally (D) an outer protective layer, and to the use thereof, in particular in paints, coatings, industrial coatings, automobile paints, automotive refinish paints, coil coating, powder coatings, printing inks, plastics, pigment pastes, pigment preparations and in dry preparations, such as, for example, granules.
    Type: Grant
    Filed: December 9, 2013
    Date of Patent: March 6, 2018
    Assignee: Merck Patent GmbH
    Inventor: Christoph Schmidt
  • Patent number: 9911929
    Abstract: Claimed is a cyclometallated organometallic light emitting complex having two tridentate ligand portions sharing a central heterocycle “A” providing a binding-site for each of the two metals (formula I): Formula (I): A more illustrative embodiment is formula (XII): Characterizing for the invention is that either one of XI and X2 and either one of Y1 and Y2 is carbon. The dinuclear complexes are for use in OLEDs.
    Type: Grant
    Filed: August 17, 2016
    Date of Patent: March 6, 2018
    Assignee: Merck Patent GmbH
    Inventors: Valery Kozhevnikov, Pierre-Henri Lanoè
  • Publication number: 20180062022
    Abstract: The present invention relates to a novel printable paste in the form of a hybrid gel based on precursors of inorganic oxides which can be used in a simplified process for the production of solar cells, where the hybrid gel according to the invention functions both as doping medium and also as diffusion barrier.
    Type: Application
    Filed: March 24, 2016
    Publication date: March 1, 2018
    Applicant: Merck Patent GmbH
    Inventors: Oliver DOLL, Ingo KOEHLER, Sebastian BARTH
  • Publication number: 20180057743
    Abstract: The present invention relates to liquid-crystalline media (LC media) having negative or positive dielectric anisotropy, comprising a low-molecular-weight component and a polymerizable component. The polymerizable component comprises self-aligning, polymerizable mesogens (polymerizable self-alignment additives) which effect homeotropic (vertical) alignment of the LC media at a surface or the cell walls of a liquid-crystal display (LC display). The invention therefore also encompasses LC displays having homeotropic alignment of the LC medium without alignment layers. The invention discloses novel structures for self-alignment additives which have a certain position of the functional groups.
    Type: Application
    Filed: November 3, 2017
    Publication date: March 1, 2018
    Applicant: Merck Patent GmbH
    Inventors: Graziano ARCHETTI, Izumi SAITO, Rocco FORTTE, Thorsten KODEK
  • Patent number: 9901577
    Abstract: Compounds of the formula I in which R1-R3 and Z have the meanings indicated in Claim 1, are inhibitors of Tankyrase, and can be employed, inter alia, for the treatment of diseases such as cancer, cardiovascular diseases, central nervous system injury and different forms of inflammation.
    Type: Grant
    Filed: July 10, 2014
    Date of Patent: February 27, 2018
    Assignee: MERCK PATENT GMBH
    Inventors: Dieter Dorsch, Hans-Peter Buchstaller
  • Publication number: 20180053873
    Abstract: The present invention relates to a novel printable medium in the form of a hybrid sol and/or gel based on precursors of inorganic oxides for use in a simplified process for the production of solar cells, in which the medium according to the invention functions both as doping medium and also as diffusion barrier.
    Type: Application
    Filed: March 24, 2016
    Publication date: February 22, 2018
    Applicant: Merck Patent GmbH
    Inventors: Oliver DOLL, Ingo KOEHLER, Sebastian BARTH
  • Publication number: 20180051206
    Abstract: The present invention relates to a compound of formula (I) or (II), which is suitable for use as functional material in an electronic device, in particular as emitter material in an organic electroluminescent device.
    Type: Application
    Filed: February 26, 2016
    Publication date: February 22, 2018
    Applicant: Merck Patent GmbH
    Inventors: Beate Burkhart, Holger Heil, Lara-lsabel Rodriguez, Sebastian Meyer, Amandine Darsy, Rouven Linge
  • Patent number: 9896764
    Abstract: The present invention provides a method for forming a siliceous film. According to the method, a siliceous film having a hydrophilic surface can be formed from a polysilazane compound at a low temperature. In the method, a composition containing a polysilazane compound and a silica-conversion reaction accelerator is applied on a substrate surface to form a polysilazane film, and then a polysilazane film-treatment solution is applied thereon so that the polysilazane compound can be converted into a siliceous film at 300° C. or less. The polysilazane film-treatment solution contains a solvent, hydrogen peroxide and an alcohol.
    Type: Grant
    Filed: September 2, 2010
    Date of Patent: February 20, 2018
    Assignee: Merck Patent GmbH
    Inventors: Yuki Ozaki, Masanobu Hayashi
  • Publication number: 20180046080
    Abstract: The present invention relates to a photosensitive composition comprising at least one nanosized fluorescent material and polysiloxane, to a color conversion film, and to a use of the color conversion film in an optical device. The invention further relates to an optical device comprising the color conversion film and a method for preparing the color conversion film and the optical device.
    Type: Application
    Filed: February 5, 2016
    Publication date: February 15, 2018
    Applicants: Merck Patent GmbH, AZ Electronic Materials (Luxembourg) S.a.r.l.
    Inventors: Masayoshi SUZUKI, Tadashi KISHIMOTO, Yuki HIRAYAMA, Stephan DERTINGER, Toshiaki NONAKA, Daishi YOKOYAMA
  • Publication number: 20180044591
    Abstract: The present invention relates to a liquid crystal (LC) medium comprising a polymerizable compound, to a process for its preparation, to its use for optical, electro-optical and electronic purposes, in particular in LC displays, especially in an LC display of the polymer sustained alignment (PSA) type, and to an LC display, especially a PSA display, comprising it.
    Type: Application
    Filed: August 4, 2017
    Publication date: February 15, 2018
    Applicant: MERCK PATENT GMBH
    Inventors: Ji-Won JEONG, Eun-Kyu LEE, Hyun-Jin YOON, Min-Ok JIN, Yong-Kuk YUN